Evidence map›Paper›PMID 37265570›Full record

ArticleFrontiers in cardiovascular medicine2023

The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension.

Jiaming Xiu, Xueqin Lin, Qiansheng Chen, Pei Yu, Jin Lu, Yanfang Yang, Weihua Chen, Kunming Bao, Junjie Wang, Jinlong Zhu and 5 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jiaming Xiu *Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Xueqin Lin *Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Qiansheng Chen *Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Pei YuDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Jin LuDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Yanfang YangDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Weihua ChenDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Kunming BaoDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Junjie WangDepartment of Cardiology, Fuzhou First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Jinlong ZhuDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Xiaoying ZhangDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Yuxiong PanDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Jiabin TuDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Kaihong ChenDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Liling ChenDepartment of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Inflammation plays an important role in the pathophysiology of hypertension (HTN). Aggregate index of systemic inflammation (AISI), as a new inflammatory and prognostic marker has emerged recently. Our goal was to determine whether there was a relationship between HTN and AISI. Methods: We analyzed patients with HTN from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. The primary end point was cardiovascular mortality. A total of 23,765 participants were divided into four groups according to the AISI quartile level. The association between AISI and cardiovascular mortality in patients with HTN was assessed by survival curves and Cox regression analyses based on NHANES recommended weights. Results: High levels of AISI were significantly associated with cardiovascular mortality in patients with HTN. After full adjustment for confounders, there was no significant difference in the risk of cardiovascular mortality in Q2 and Q3 compared to Q1, while Q4 (HR: 1.91, 95% CI: 1.42-2.58; Conclusions: In adults with HTN, elevated AISI levels are significantly associated with an increased risk of cardiovascular mortality and may serve as an early warning parameter for poor prognosis.

Indexed as

aggregate index of systemic inflammationcardiovascular mortalityhypertensioninflammationNHANES

Identifiers

PMID37265570
PMCPMC10229810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.